The Structure and Parameterization of the Breast Cancer Transition Model Among Chinese Women

被引:3
作者
Huang, Yuan [1 ,2 ]
Li, Qin [2 ,3 ]
Torres-Rueda, Sergio [4 ]
Li, Jiayuan [2 ]
机构
[1] Kunming Med Univ, Sch Publ Hlth, Kunming, Yunnan, Peoples R China
[2] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Matern & Child Care Hosp, Chengdu, Sichuan, Peoples R China
[4] London Sch Hyg & Trop Med, London, England
关键词
breast cancer; disease transition model; Markov model; transition probability; validity analysis; COST-EFFECTIVENESS ANALYSIS; NATURAL-HISTORY; GLOBAL BURDEN; HEALTH-CARE; MAMMOGRAPHY; COUNTRIES; DISEASE; PRINCIPLES; POLICIES;
D O I
10.1016/j.vhri.2019.05.003
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: Markov model simulation based on the natural history of disease is commonly employed for the comparative research of health interventions. The present study aims to simulate the natural progression of breast cancer and parameterize the initial and transition probabilities of multiple states of breast cancer development among Chinese women. Methods: The age-specific incidence, mortality, and clinical stage distribution of breast cancer; and relapse rate of each clinical stage were collected from China's cancer registry yearbooks and clinical epidemiological studies to simulate the process from full health to breast cancer to death among Chinese women aged 30 to 80 through a Markov cohort study. The validity analysis was conducted to evaluate the accuracy of the model estimation. Results: A Markov transition model with 7 states (no breast cancer, clinical stages 0-IV breast cancer, and death) was constructed for Chinese women. The age-specific incidence, mortality, and clinical stage distribution of breast cancer estimated by the initial and transition probabilities among different Markov states were highly consistent with the registered data and observed studies. Conclusion: A breast cancer transition model for Chinese women has been established with validity. It could be a point of reference for further economic evaluations and breast cancer screening policy formulation.
引用
收藏
页码:29 / 38
页数:10
相关论文
共 64 条
[1]  
American Cancer Society, NONC BREAST COND
[2]  
[Anonymous], 2002, Methods for the Economic Evaluation of Health Care Programmes
[3]  
[Anonymous], 1982, International and business forecasting methods
[4]  
[Anonymous], 1991, Econometric Models and Economic Forecasts
[5]   Building a model to determine the cost-effectiveness of breast cancer screening in France [J].
Arveux, P ;
Wait, S ;
Schaffer, P .
EUROPEAN JOURNAL OF CANCER CARE, 2003, 12 (02) :143-153
[6]   Systematic review: The long-term effects of false-positive mammograms [J].
Brewer, Noel T. ;
Salz, Talya ;
Lillie, Sarah E. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (07) :502-510
[7]   An introduction to Markov modelling for economic evaluation [J].
Briggs, A ;
Sculpher, M .
PHARMACOECONOMICS, 1998, 13 (04) :397-409
[8]   Pharmacoeconamic analyses using discrete event simulation [J].
Caro, JJ .
PHARMACOECONOMICS, 2005, 23 (04) :323-332
[9]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[10]   Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration [J].
Chia, YL ;
Salzman, P ;
Plevritis, SK ;
Glynn, PW .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2004, 13 (06) :507-524